Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2
- PMID: 15328897
Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2
Abstract
Gallbladder carcinoma and carcinoma of the bile ducts are relatively rare cancers in the United States. These cancers are often diagnosed in an advanced stage due to their nonspecific symptomatology and until recently have been associated with a dismal prognosis. Recent advances in imaging and surgical techniques along with emerging options in palliative chemotherapy have improved the outlook in these cancers. While complete surgical resection remains the only hope of cure in both these cancers, palliative biliary decompression and chemotherapy result in substantial improvement in quality of life. Part 1 of this review, which appeared in last month's issue, provided a relevant and comprehensive update of molecular pathology, imaging modalities, and surgical care. In part 2, we examine palliative care and systemic therapy in gallbladder and biliary tract carcinomas, as well as the use of liver transplantation in the treatment of cholangiocarcinomas. These strategies are of relevance to internists as well as oncologists caring for these patients.
Similar articles
-
Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1.Oncology (Williston Park). 2004 Jun;18(7):889-96. Oncology (Williston Park). 2004. PMID: 15255172 Review.
-
Regional chemotherapy in biliary tract cancers--a single institution experience.Hepatogastroenterology. 2002 Jul-Aug;49(46):900-6. Hepatogastroenterology. 2002. PMID: 12143237
-
[Management of biliary tract carcinomas].Rev Prat. 2009 Apr 20;59(4):469-73. Rev Prat. 2009. PMID: 19462864 French.
-
Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy.Crit Rev Oncol Hematol. 2007 Jan;61(1):44-51. doi: 10.1016/j.critrevonc.2006.07.006. Crit Rev Oncol Hematol. 2007. PMID: 17164111 Review.
-
Malignancies of the biliary tree.Curr Probl Surg. 1995 Jan;32(1):1-90. doi: 10.1016/s0011-3840(05)80011-5. Curr Probl Surg. 1995. PMID: 7528652 Review. No abstract available.
Cited by
-
Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.Oncotarget. 2015 Sep 15;6(27):23857-73. doi: 10.18632/oncotarget.4408. Oncotarget. 2015. PMID: 26160843 Free PMC article.
-
High Response Rate and Prolonged Survival of Unresectable Biliary Tract Cancer Treated With a New Combination Therapy Consisting of Intraarterial Chemotherapy Plus Radiotherapy.Front Oncol. 2020 Nov 17;10:597813. doi: 10.3389/fonc.2020.597813. eCollection 2020. Front Oncol. 2020. PMID: 33312956 Free PMC article.
-
A pathologic complete response in the surgical specimen after systemic chemotherapy for a gallbladder carcinoma.Gastrointest Cancer Res. 2012 May;5(3):106-8. Gastrointest Cancer Res. 2012. PMID: 22888393 Free PMC article. No abstract available.
-
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):148-53. doi: 10.1016/j.ijrobp.2008.07.008. Epub 2008 Sep 19. Int J Radiat Oncol Biol Phys. 2009. PMID: 18805651 Free PMC article.
-
Expression of multidrug resistance-associated protein 2 in human gallbladder carcinoma.Biomed Res Int. 2013;2013:527534. doi: 10.1155/2013/527534. Epub 2013 Jun 16. Biomed Res Int. 2013. PMID: 23841074 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical